Publications by authors named "M Octave-Prignot"

Claim this Profile
P
Pulmonary embolism: radiation dose with multi-detector row CT and digital angiography for diagnosis.
Emmanuel Coche, Stefaan Vynckier, Michelle Octave-Prignot

Radiology· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study.
J-P Machiels, L Duck, B Honhon, B Coster, J-C Coche, M Octave-Prignot

Ann Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal crypt regeneration in mice: a biological system for quality assurance in non-conventional radiation therapy.
John Gueulette, Michèle Octave-Prignot, Blanche-Marie De Costera, André Wambersie, Vincent Grégoire

Radiother Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas.
Jean-François Rosier, Monique Bruniaux, Bernard Husson, Michelle Octave-Prignot, Marc Beauduin

Radiother Oncol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs.
Jean-François Rosier, Lucienne Michaux, Geneviève Ameye, Björn Cedervall, Jeanne-Marie Libouton, Michèle Octave-Prignot

Mutat Res· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis